FOLH1 and colon carcinoma: After radiolabeling of PSMA-N064 with 111In, an increased tumor uptake of up to 2 h post injection (13.1 ± 2.3% ID/g) was determined in mice bearing LS1754T colon carcinoma cells transfected with human PSMA (LS1754T-PSMA).